1,542 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Acquired by Valmark Advisers Inc.

Valmark Advisers Inc. bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, Holdings Channel reports. The fund bought 1,542 shares of the financial services provider’s stock, valued at approximately $204,000.

A number of other large investors have also recently added to or reduced their stakes in the business. Chicago Partners Investment Group LLC boosted its holdings in iShares Biotechnology ETF by 2.5% during the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock worth $510,000 after buying an additional 94 shares in the last quarter. Capital Investment Advisors LLC boosted its holdings in iShares Biotechnology ETF by 1.0% during the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after buying an additional 99 shares in the last quarter. Magnus Financial Group LLC boosted its holdings in iShares Biotechnology ETF by 0.8% during the fourth quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock worth $1,714,000 after buying an additional 104 shares in the last quarter. Daiwa Securities Group Inc. boosted its holdings in iShares Biotechnology ETF by 12.0% during the third quarter. Daiwa Securities Group Inc. now owns 1,028 shares of the financial services provider’s stock worth $150,000 after buying an additional 110 shares in the last quarter. Finally, Aptus Capital Advisors LLC boosted its stake in iShares Biotechnology ETF by 36.5% in the 3rd quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after purchasing an additional 114 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.4 %

NASDAQ IBB opened at $137.11 on Wednesday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The firm’s 50 day moving average price is $135.55 and its two-hundred day moving average price is $140.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.